Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
She joins Enveda from Gilead Sciences
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Plant is part of the company's CAD $30 million capital investment in the site
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Subscribe To Our Newsletter & Stay Updated
